{"database": "lobbying", "table": "lobbying_activities", "rows": [[2020925, "74e70921-0b55-4f83-8721-7cad75d3ff48", "Q3", "HOLLAND & KNIGHT LLP", 18466, "THE BIOSIMILARS FORUM", 2017, "third_quarter", "MED", "Medicare reimbursement issues, FDA regulation of biosimilars;  S. 934, H.R. 2430, the FDA Reauthorization Act of 2017.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2017-10-09T15:40:15.367000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2020925"], "units": {}, "query_ms": 0.3091460093855858, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}